IBBQ
IBBQ
About Invesco Nasdaq Biotechnology ETF
The Invesco Nasdaq Biotechnology ETF (Fund) is based on the Nasdaq Biotechnology Index (Index). The Fund will normally invest at least 90% of its total assets in the securities that comprise the Index. The Index is designed to measure the performance of securities listed on the Nasdaq Stock Market that are classified as either biotechnology or pharmaceutical companies. The Fund and the Index are...
About Invesco Nasdaq Biotechnology ETF
The Invesco Nasdaq Biotechnology ETF (Fund) is based on the Nasdaq Biotechnology Index (Index). The Fund will normally invest at least 90% of its total assets in the securities that comprise the Index. The Index is designed to measure the performance of securities listed on the Nasdaq Stock Market that are classified as either biotechnology or pharmaceutical companies. The Fund and the Index are...
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
 GILD | Gilead Sciences, Inc. | 7.39% | 37.04K | $4.98M |
 VRTX | Vertex Pharmaceuticals Incorporated | 7.37% | 11.10K | $4.97M |
 AMGN | Amgen Inc. | 7.16% | 14.21K | $4.79M |
 REGN | Regeneron Pharmaceuticals, Inc. | 5.09% | 5.57K | $3.42M |
 ALNY | Alnylam Pharmaceuticals, Inc. | 3.19% | 7.11K | $2.15M |
 RVMD | Revolution Medicines, Inc. | 2.48% | 10.62K | $1.67M |
 BIIB | Biogen Inc. | 2.29% | 7.87K | $1.54M |
 ILMN | Illumina, Inc. | 1.98% | 8.20K | $1.34M |
 UTHR | United Therapeutics Corporation | 1.94% | 2.35K | $1.31M |
 RPRX | Royalty Pharma plc | 1.91% | 22.97K | $1.28M |
 ARGX | argenx SE | 1.89% | 1.52K | $1.27M |
 INSM | Insmed Incorporated | 1.83% | 11.56K | $1.24M |
 ROIV | Roivant Sciences Ltd. | 1.71% | 38.37K | $1.15M |
 INCY | Incyte Corporation | 1.53% | 10.67K | $1.03M |
 VTRS | Viatris Inc. | 1.50% | 61.73K | $1.00M |
 MRNA | Moderna, Inc. | 1.48% | 21.17K | $999.15K |
 GH | Guardant Health, Inc. | 1.35% | 7.03K | $911.98K |
 NBIX | Neurocrine Biosciences, Inc. | 1.26% | 5.38K | $851.81K |
 JAZZ | Jazz Pharmaceuticals plc | 1.16% | 3.30K | $780.42K |
 ASND | Ascendis Pharma A/S | 1.10% | 3.30K | $739.79K |
SECTOR HOLDINGS
Healthcare
Cash & Others
Financial ServicesASSET ALLOCATION BY REGION
United States
Netherlands
United Kingdom
Ireland
France
Denmark
Germany
Canada
Switzerland
Bermuda
Jersey
Singapore
Iceland
Spain
Cayman Islands
Australia
China
Israel.svg)
Taiwan (Province of China)SECTOR HOLDINGS
Healthcare Cash & Others Financial ServicesASSET ALLOCATION BY REGION
United States Netherlands United Kingdom Ireland France Denmark Germany Canada Switzerland Bermuda Jersey Singapore Iceland Spain Cayman Islands Australia China Israel Taiwan (Province of China)Holdings (Top 20)
GILD
Gilead Sciences, Inc.
VRTX
Vertex Pharmaceuticals Incorporated
AMGN
Amgen Inc.
REGN
Regeneron Pharmaceuticals, Inc.
ALNY
Alnylam Pharmaceuticals, Inc.
RVMD
Revolution Medicines, Inc.
BIIB
Biogen Inc.
ILMN
Illumina, Inc.
UTHR
United Therapeutics Corporation
RPRX
Royalty Pharma plc
ARGX
argenx SE
INSM
Insmed Incorporated
ROIV
Roivant Sciences Ltd.
INCY
Incyte Corporation
VTRS
Viatris Inc.
MRNA
Moderna, Inc.
GH
Guardant Health, Inc.
NBIX
Neurocrine Biosciences, Inc.
JAZZ
Jazz Pharmaceuticals plc
ASND
Ascendis Pharma A/S